Vingerhoets J H, Vanham G L, Kestens L L, Penne G G, Colebunders R L, Vandenbruaene M J, Goeman J, Gigase P L, De Boer M, Ceuppens J L
Department of Infection and Immunity, Institute of Tropical Medicine, Antwerp, Belgium.
Clin Exp Immunol. 1995 Jun;100(3):425-33. doi: 10.1111/j.1365-2249.1995.tb03717.x.
The CD28 receptor on CD4+ and CD8+ T cells interacts with B7 molecules on antigen-presenting cells (APC) to generate essential costimulatory signals. The cytolytic potential of CD8+ T cells could be linked to CD28 expression. Since HIV induces dysfunction of both CD4+ and CD8+ T cells, we evaluated CD28 expression and function in both subsets during HIV infection. CD28 expression on CD8+ T cells from HIV+ subjects was strongly reduced in a disease stage-related fashion. CD28- CD8+ T cells preferentially expressed CD57 and CD11b, but lacked CD26 and IL-2R alpha. The CD8+ T cells from the patients showed a significantly reduced proliferative response to co-stimulation with cell-bound anti-CD3 and B7. Nevertheless, when stimulated with plate-fixed anti-CD3, CD8+ T cells from HIV-infected subjects proliferated normally, and normal levels of IL-2R alpha and transferrin-receptor could be induced on CD28- CD8+ T cells from the patients. In addition, stimulation with plate-fixed anti-CD3 induced proliferative responses in highly purified CD28- CD8+ T cells from both HIV- and HIV+ persons. Furthermore, the increased cytotoxic activity of peripheral blood mononuclear cells (PBMC) from HIV+ subjects, measured in an anti-CD3 redirected assay, was predominantly exerted by CD28- CD57+ T cells. CD4+ T cells from the patients showed a slight but significant CD28 down-regulation and were slightly hyporesponsive to B7 co-stimulation. Decrease of CD28 on CD8+ T cells from HIV+ subjects is associated with an impaired response to co-stimulation via B7. CD28- CD8+ T cells from seropositives, however, are not completely inert, since they contain in vivo activated CTL and they can be additionally activated through a B7-independent stimulation.
CD4+和CD8+ T细胞上的CD28受体与抗原呈递细胞(APC)上的B7分子相互作用,以产生重要的共刺激信号。CD8+ T细胞的细胞溶解潜能可能与CD28表达有关。由于HIV可诱导CD4+和CD8+ T细胞功能障碍,我们评估了HIV感染期间这两个亚群中CD28的表达和功能。HIV+受试者CD8+ T细胞上的CD28表达以疾病阶段相关的方式显著降低。CD28-CD8+ T细胞优先表达CD57和CD11b,但缺乏CD26和IL-2Rα。患者的CD8+ T细胞对与细胞结合的抗CD3和B7共刺激的增殖反应显著降低。然而,当用平板固定的抗CD3刺激时,HIV感染受试者的CD8+ T细胞正常增殖,并且患者的CD28-CD8+ T细胞上可诱导出正常水平的IL-2Rα和转铁蛋白受体。此外,用平板固定的抗CD3刺激可诱导HIV-和HIV+个体高度纯化的CD28-CD8+ T细胞产生增殖反应。此外,在抗CD3重定向测定中测量的HIV+受试者外周血单核细胞(PBMC)细胞毒性活性增加主要由CD28-CD57+ T细胞发挥。患者的CD4+ T细胞显示出轻微但显著的CD28下调,并且对B7共刺激略有反应低下。HIV+受试者CD8+ T细胞上CD28的减少与通过B7的共刺激反应受损有关。然而,血清阳性者的CD28-CD8+ T细胞并非完全无活性,因为它们含有体内活化的CTL,并且它们可以通过不依赖B7的刺激而被额外激活。